Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Nearly 2,000 People Living With HIV along with MSF & other civil society organisations rallied in the streets of New Delhi at the start of the EU-India summit. They warned that harmful provisions in a trade deal being negotiated between the EU and India could severely hinder access to affordable medicine for people in developing countries. Photograph by Siddharth Singh
Press release
Press release |
10 February 2012
HIV/AIDS Intellectual property and trade
European UnionIndia

EU-India Trade Deal Could Cut Medicines Lifeline for People in Developing Countries

4 min
Press release |
30 January 2012
Intellectual property and trade Research and development Tropical & neglected diseases

Combating Neglected Tropical Diseases: What is Still Missing

When I found out I was HIV-positive, I collapsed. I was like you see in this photo: in a really bad state. I thought, "If I'm ill, what will happen to my children?" I thought I was going to die. On the radio and television, there are always songs about how Aids kills. And people say that anyone with Aids won't last long. Photograph by Elisee
Press release
Press release |
25 January 2012
HIV/AIDS Intellectual property and trade

85% of AIDS patients deprived of treatment in DRC

Press release |
21 December 2011

MSF holds its first international general assembly, marks fortieth anniversary

In Kacheliba, MSF offers a free treatment for patients affected by visceral leishmaniasis, commonly known as Kala-Azar. This disease, which can be fatal if not treated, is transmitted by sand flies Photograph by Frederik Matte
Press release
Press release |
08 December 2011
HIV/AIDS Tropical & neglected diseases
EthiopiaKenyaSudan

East African HIV programmes must wake up to visceral leishmaniasis

4 min
In this women's ward in Homa Bay District hospital in western Kenya, patients are treated for cryptococcal meningitis and other opportunistic infections. Photograph by David Levene
Press release
Press release |
07 December 2011
HIV/AIDS Intellectual property and trade Tropical & neglected diseases
Ethiopia

First-Ever Treatment Guidelines Released for Major Cause of Death of People Living with HIV

Press release |
03 December 2011
HIV/AIDS Intellectual property and trade Tropical & neglected diseases Tuberculosis

At African AIDS Conference, MSF Calls For Increased Funding for HIV Treatment

Press release |
22 November 2011
HIV/AIDS Intellectual property and trade Malaria Tuberculosis

MSF response to unprecedented decision to cancel funding round of the Global Fund to Fight AIDS, TB & Malaria

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury